Antivirals such as SIGA Technologies, Inc's tecovirimat, Chimerix, Inc.'s brincidofovir (Tembexa) and generic cidofovir can be used in cases of severe monkeypox disease, preferably in the context of randomized clinical trials with the collection of standardized clinical and outcomes data to quickly generate safety and efficacy data, the World Health Organization advises in its latest guidance.
If clinical trials are not possible, antivirals may be used under expanded access protocols such as MEURI (monitored emergency use...








